MolecuLight's advanced fluorescence imaging technology is featured in a new study in the popular Burns Journal page 1

toronto, May 30, 2024 /PRNewswire/ — MolecuLight Inc., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria in wound care, celebrates the publication of a groundbreaking study in the prestigious journal Burns. Under the title “Bacterial fluorescence imaging as a predictor of skin graft integration in burn wounds.” The study demonstrates the unparalleled potential of the innovative MolecuLight technology in predicting the outcomes of skin graft incorporation into burn wounds.

this study To examine the predictive capabilities of MolecuLight fluorescence imaging in assessing the presence of bacteria that may be associated with skin graft failure in burn wounds. The results showed significant correlations between the presence or absence of bacteria (more than 10⁴ CFU/gr tissue) on the graft layer immediately before skin grafting and graft failure or success.

Key findings of the study include:

• The absence of fluorescence signals resulted in a completion rate of 99.2% per cm²While its presence increases the finishing percentage to 27.9% per cm² reduced.
• Fluoroscopic imaging predicted bacteria-associated graft loss with a specificity of 98%.
• A high probability of graft success was noted in areas with negative fluorescent signals (negative predictive value 99-100%).
• No bacterial growth can be detected at most organ transplant sites on the standard swabs currently used as the standard method for determining suitability for transplantation.

“These compelling results underscore the transformative impact of MolecuLight in the treatment of burn wounds – another area of ​​wound care where our technology is driving change,” said Anil Amlani, CEO of MolecuLight Inc. “By providing objective, real-time data regarding the presence of bacteria, MolecuLight’s fluorescence imaging technology allows clinicians to make more informed decisions, ultimately leading to better patient outcomes. The results of this study indicate that removing fluorescence signals at the implant site has the potential to Improving transplant acceptance.